Avermectin BINF1/INF and its delta-8,9-isomer; Pesticide Tolerances, 39545-39551 [E9-19006]
Download as PDF
pwalker on DSK8KYBLC1PROD with RULES
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
Pursuant to the Regulatory Flexibility
Act (RFA) (5 U.S.C. 601 et seq.), the
Agency hereby certifies that this action
will not have a significant negative
economic impact on a substantial
number of small entities.
In addition, the Agency has
determined that this action will not
have a substantial direct effect on States,
on the relationship between the national
government and the States, or on the
distribution of power and
responsibilities among the various
levels of government, as specified in
Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999). Executive Order 13132 requires
EPA to develop an accountable process
to ensure ‘‘meaningful and timely input
by State and local officials in the
development of regulatory policies that
have federalism implications.’’ ‘‘Policies
that have federalism implications’’ is
defined in the Executive Order to
include regulations that have
‘‘substantial direct effects on the States,
on the relationship between the national
government and the States, or on the
distribution of power and
responsibilities among the various
levels of government.’’ This rule directly
regulates growers, food processors, food
handlers, and food retailers, not States.
This action does not alter the
relationships or distribution of power
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. For these
same reasons, the Agency has
determined that this rule does not have
any ‘‘tribal implications’’ as described
in Executive Order 13175, entitled
Consultation and Coordination with
Indian Tribal Governments (65 FR
67249, November 9, 2000). Executive
Order 13175 requires EPA to develop an
accountable process to ensure
‘‘meaningful and timely input by tribal
officials in the development of
regulatory policies that have tribal
implications.’’ ‘‘Policies that have tribal
implications’’ is defined in the
Executive order to include regulations
that have ‘‘substantial direct effects on
one or more Indian tribes, on the
relationship between the Federal
Government and the Indian tribes, or on
the distribution of power and
responsibilities between the Federal
Government and Indian tribes.’’ This
rule will not have substantial direct
effects on tribal governments, on the
relationship between the Federal
Government and Indian tribes, or on the
distribution of power and
responsibilities between the Federal
Government and Indian tribes, as
specified in Executive Order 13175.
VerDate Nov<24>2008
19:32 Aug 06, 2009
Jkt 217001
Thus, Executive Order 13175 does not
apply to this rule.
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: August 4, 2009.
G. Jeffrey Herndon,
Acting Director, Registration Division, Office
of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
■
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
§180.910
[Amended]
2. In the final rule published August
9, 2006 (71 FR 45415), and delayed on
August 4, 2008 (73 FR 45312), the
effective date is delayed from August 9,
2009, to October 9, 2009, for the
following amendments to § 180.910:
2.m., n., and cc.
■
§180.930
[Amended]
3. In the final rule published August
9, 2006 (71 FR 45415), and delayed on
August 4, 2008 (73 FR 45312), the
effective date is delayed from August 9,
2009, to October 9, 2009, for the
following amendments to § 180.930:
4.t., u., and v.
■
[FR Doc. E9–19057 Filed 8–6–09; 8:45 am]
BILLING CODE 6560–50–S
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2008–0806; FRL–8427–7]
Avermectin B1 and its delta-8,9-isomer;
Pesticide Tolerances
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Final rule.
SUMMARY: This regulation establishes
tolerances for combined residues of
avermectin B1 and its delta-8,9-isomer
in or on stone fruit crop group 12, tree
nut crop group 14, pistachio, tuberous
and corm vegetable crop subgroup 01C,
goat fat, hog fat, horse fat, sheep fat,
cattle fat, and cattle meat byproducts.
Existing tolerances for cattle, fat and
cattle, meat byproducts are revised.
Existing individual crop tolerances on
almond, plum, potato, and walnut are
deleted and replaced by the
PO 00000
Frm 00011
Fmt 4700
Sfmt 4700
39545
establishment of new crop group
tolerances. Existing tolerances on
almond, hulls and plum, prune, dried
are retained. This regulation also makes
a technical correction to correctly
express the existing tolerances for mint
(replace term ‘‘mint’’ with the more
specific terms ‘‘peppermint, tops’’ and
‘‘spearmint, tops’’). Syngenta Crop
Protection, Inc. and Y-TEX Corporation
requested these tolerances under the
Federal Food, Drug, and Cosmetic Act
(FFDCA).
DATES: This regulation is effective
August 7, 2009. Objections and requests
for hearings must be received on or
before October 6, 2009, and must be
filed in accordance with the instructions
provided in 40 CFR part 178 (see also
Unit I.C. of the SUPPLEMENTARY
INFORMATION).
ADDRESSES: EPA has established a
docket for this action under docket
identification (ID) number EPA–HQ–
OPP–2008–0806. All documents in the
docket are listed in the docket index
available at https://www.regulations.gov.
Although listed in the index, some
information is not publicly available,
e.g., Confidential Business Information
(CBI) or other information whose
disclosure is restricted by statute.
Certain other material, such as
copyrighted material, is not placed on
the Internet and will be publicly
available only in hard copy form.
Publicly available docket materials are
available in the electronic docket at
https://www.regulations.gov, or, if only
available in hard copy, at the OPP
Regulatory Public Docket in Rm. S–
4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The
Docket Facility is open from 8:30 a.m.
to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket
Facility telephone number is (703) 305–
5805.
FOR FURTHER INFORMATION CONTACT:
Thomas C. Harris, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001; telephone number:
(703) 308-9423; e-mail address:
harris.thomas@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. Potentially
affected entities may include, but are
not limited to those engaged in the
following activities:
E:\FR\FM\07AUR1.SGM
07AUR1
39546
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
• Crop production (NAICS code
111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
This listing is not intended to be
exhaustive, but rather to provide a guide
for readers regarding entities likely to be
affected by this action. Other types of
entities not listed in this unit could also
be affected. The North American
Industrial Classification System
(NAICS) codes have been provided to
assist you and others in determining
whether this action might apply to
certain entities. If you have any
questions regarding the applicability of
this action to a particular entity, consult
the person listed under FOR FURTHER
INFORMATION CONTACT.
pwalker on DSK8KYBLC1PROD with RULES
B. How Can I Access Electronic Copies
of this Document?
In addition to accessing electronically
available documents at https://
www.regulations.gov, you may access
this Federal Register document
electronically through the EPA Internet
under the ‘‘Federal Register’’ listings at
https://www.epa.gov/fedrgstr. You may
also access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
cite at https://www.gpoaccess.gov/ecfr.
To access the OPPTS Harmonized
Guidelines referenced in this document,
go directly to the guidelines at https://
www.epa.gov/opptsfrs/home/
guidelin.htm.
C. Can I File an Objection or Hearing
Request?
Under section 408(g) of FFDCA, 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2008–0806 in the subject line on
the first page of your submission. All
requests must be in writing, and must be
mailed or delivered to the Hearing Clerk
as required by 40 CFR part 178 on or
before October 6, 2009.
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing that does not
contain any CBI for inclusion in the
public docket that is described in
ADDRESSES. Information not marked
VerDate Nov<24>2008
15:59 Aug 06, 2009
Jkt 217001
confidential pursuant to 40 CFR part 2
may be disclosed publicly by EPA
without prior notice. Submit this copy,
identified by docket ID number EPA–
HQ–OPP–2008–0806, by one of the
following methods:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
on-line instructions for submitting
comments.
• Mail: Office of Pesticide Programs
(OPP) Regulatory Public Docket (7502P),
Environmental Protection Agency, 1200
Pennsylvania Ave., NW., Washington,
DC 20460–0001.
• Delivery: OPP Regulatory Public
Docket (7502P), Environmental
Protection Agency, Rm. S–4400, One
Potomac Yard (South Bldg.), 2777 S.
Crystal Dr., Arlington, VA. Deliveries
are only accepted during the Docket
Facility’s normal hours of operation
(8:30 a.m. to 4 p.m., Monday through
Friday, excluding legal holidays).
Special arrangements should be made
for deliveries of boxed information. The
Docket Facility telephone number is
(703) 305–5805.
II. Petition for Tolerance
As listed below, EPA published
notices pursuant to section 408(d)(3) of
FFDCA, 21 U.S.C. 346a(d)(3),
announcing the filing of pesticide
petitions in the Federal Register
requesting that 40 CFR 180.449 be
amended by establishing a tolerance for
combined residues of the insecticide/
miticide avermectin B1 (a mixture of
avermectins containing greater than or
equal to 80% avermectin B1a (5-Odemethyl avermectin A1) and less than
or equal to 20% avermectin B1b (5-Odemethyl-25-de (1-methylpropyl)-25-(1methylethyl) avermectin A1)), and its
delta-8,9-isomer, as listed below.
Avermectin B1 is also referred to as
abamectin. Each notice included a
summary of the petition prepared by the
registrant listed. There were no
comments received in response to these
notices of filing.
September 27, 2000, 65 FR 58080,
FRL–6746–4, PP 0F6146. This petition
was filed by Novartis Crop Protection,
Inc. (now Syngenta Crop Protection,
Inc.), P.O. Box 18300, Greensboro, NC
27419–8300 for tolerances of avermectin
B1 and its delta-8,9-isomer in or on grass
forage at 0.001 ppm, grass hay at 0.001
ppm, stone fruit crop group 12 at 0.015
ppm, tree nut crop group 14 at 0.005
ppm, pistachio at 0.005 ppm, and the
tuberous and corm vegetable crop
subgroup 01C at 0.005 ppm. Tolerances
for avocado and mint which were also
requested in that notice were
established earlier (see February 16,
2005, 70 FR 7876).
PO 00000
Frm 00012
Fmt 4700
Sfmt 4700
Based upon EPA review of the data
supporting the petition, the petition was
subsequently amended to request
permanent tolerances for avermectin B1
and its delta-8,9-isomer at the revised
levels as follow: Stone fruit crop group
12 at 0.09 ppm, tree nut crop group 14
at 0.01 ppm, pistachios at 0.01 ppm,
tuberous and corm vegetables crop
subgroup 01C at 0.01 ppm, goat fat at
0.01 ppm, hog fat at 0.01 ppm, horse fat
at 0.01 ppm, and sheep fat at 0.01 ppm.
The tolerance requests for grass hay and
grass forage were withdrawn pending
development of further data on grass
hay. Existing individual crop tolerances
on almond, plum, potato, and walnut
are deleted and replaced by the
establishment of new crop group
tolerances. Existing tolerances on
almond, hulls and plum, prune, dried
are retained. The proposed tolerance
levels were raised based on EPA’s
analysis of the residue data, EPA’s
assessment of the limits of quantitation
(LOQs) of the analytical methods,
current livestock feed items (OPPTS
Guideline 860.100, Table 1 Feedstuffs,
June 2008), and/or to coordinate with
Codex Maximum Residue Limits (MRLs)
(see Unit IV.B.).
December 3, 2008, 73 FR 73648, FRL–
8391–3, PP 8F7454. This petition was
filed by Y-TEX Corporation, 1825 Big
Horn Avenue, P.O. Box 1450, Cody, WY
82414, and proposes to amend the
tolerances in 40 CFR 180.449 by
increasing the tolerances of avermectin
B1 and its delta-8,9-isomer in or on
cattle fat from 0.015 ppm to 0.03 ppm
and cattle meat byproducts from 0.02
ppm to 0.06 ppm. These tolerances
support use of avermectin in cattle ear
tags.
This regulation also makes a technical
amendment to correctly express the
existing tolerances for mint which were
established in the final rule published
on February 16, 2005 (70 FR 7876) (FRL7695-7). That rule listed the tolerance as
‘‘mint’’ at 0.010 ppm. The correct
terminology is ‘‘peppermint, tops’’ at
0.010 ppm and ‘‘spearmint, tops’’ at
0.010 ppm.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
E:\FR\FM\07AUR1.SGM
07AUR1
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
pwalker on DSK8KYBLC1PROD with RULES
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue....’’
Consistent with section 408(b)(2)(D)
of FFDCA, and the factors specified in
section 408(b)(2)(D) of FFDCA, EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for the petitioned-for
tolerances for combined residues of
avermectin B1 and its delta-8,9-isomer
on stone fruit crop group 12 at 0.09
ppm, tree nut crop group 14 at 0.01
ppm, pistachios at 0.01 ppm, tuberous
and corm vegetables crop subgroup 01C
at 0.01 ppm, goat fat at 0.01 ppm, hog
fat at 0.01 ppm, horse fat at 0.01 ppm,
sheep fat at 0.01 ppm, cattle fat at 0.03
ppm, and cattle meat byproducts at 0.06
ppm. EPA’s assessment of exposures
and risks associated with establishing
tolerances follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
Avermection B1 (also known as
abamectin) has high to moderate acute
toxicity by the oral route, high acute
toxicity by the inhalation route, and low
acute toxicity by the dermal route. It is
slightly irritating to the skin, but is not
an ocular irritant or a dermal sensitizer.
In general, the results of available
toxicity studies with single or repeated
dosing indicate that the main target
organ for avermection B1 is the nervous
system, and that decreased body weight
is also one of the most frequent findings.
There was no observed estrogen,
androgen, or thyroid mediated toxicity.
Neurotoxicity and developmental effects
are detected in multiple studies and
species of test animals. The dose/
response curve is very steep in several
studies, with severe effects (including
death and morbid sacrifice) seen at dose
levels as low as 0.4 milligrams/
VerDate Nov<24>2008
15:59 Aug 06, 2009
Jkt 217001
kilogram/day (mg/kg/day) and 0.1 mg/
kg/day in rats and mice, respectively,
following repeated exposures. Increased
susceptibility (qualitative and/or
quantitative) was seen in prenatal
developmental toxicity studies in mice
and rabbits, and an increase in
quantitative and qualitative
susceptibility was also seen in the rat
reproductive toxicity studies. Review of
acceptable oncogenicity and
mutagenicity studies provide no
indication that avermection B1 is
carcinogenic or mutagenic.
Specific information on the studies
received and the nature of the adverse
effects caused by avermectin B1 and its
delta-8,9-isomer as well as the noobserved-adverse-effect-level (NOAEL)
and the lowest-observed-adverse-effectlevel (LOAEL) from the toxicity studies
can be found at https://
www.regulations.gov in document the
‘‘Abamectin, Revised Human Health
Risk Assessment for Proposed Uses on
Pasture and Rangeland Grass, Stone
Fruit Crop Group 12, Tree Nut Crop
Group 14, Pistachio, Tuberous and
Corm Vegetables Subgroup 01C, and
Request for Cattle Ear Tag Use,’’ at page
18 in docket ID number EPA–HQ–OPP–
2008–0806.
B. Toxicological Endpoints
For hazards that have a threshold
below which there is no appreciable
risk, a toxicological point of departure
(POD) is identified as the basis for
derivation of reference values for risk
assessment. The POD may be defined as
the highest dose at which no adverse
effects are observed (the NOAEL) in the
toxicology study identified as
appropriate for use in risk assessment.
However, if a NOAEL cannot be
determined, the lowest dose at which
adverse effects of concern are identified
(the LOAEL) or a Benchmark Dose
(BMD) approach is sometimes used for
risk assessment. Uncertainty/safety
factors (UFs) are used in conjunction
with the POD to take into account
uncertainties inherent in the
extrapolation from laboratory animal
data to humans and in the variations in
sensitivity among members of the
human population as well as other
unknowns. Safety is assessed for acute
and chronic dietary risks by comparing
aggregate food and water exposure to
the pesticide to the acute population
adjusted dose (aPAD) and chronic
population adjusted dose (cPAD). The
aPAD and cPAD are calculated by
dividing the POD by all applicable UFs.
Aggregate short-, intermediate-, and
chronic-term risks are evaluated by
comparing food, water, and residential
exposure to the POD to ensure that the
PO 00000
Frm 00013
Fmt 4700
Sfmt 4700
39547
margin of exposure (MOE) called for by
the product of all applicable UFs is not
exceeded. This latter value is referred to
as the Level of Concern (LOC).
For non-threshold risks, the Agency
assumes that any amount of exposure
will lead to some degree of risk. Thus,
the Agency estimates risk in terms of the
probability of an occurrence of the
adverse effect greater than that expected
in a lifetime. For more information on
the general principles EPA uses in risk
characterization and a complete
description of the risk assessment
process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
A summary of the toxicological
endpoints for avermectin B1 and its
delta-8,9-isomer used for human risk
assessment can be found at https://
www.regulations.gov in the document
‘‘Abamectin, Revised Human Health
Risk Assessment for Proposed Uses on
Pasture and Rangeland Grass, Stone
Fruit Crop Group 12, Tree Nut Crop
Group 14, Pistachio, Tuberous and
Corm Vegetables Subgroup 01C, and
Request for Cattle Ear Tag Use,’’ at page
25 in docket ID number EPA–HQ–OPP–
2008–0806.
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to avermectin B1 and its delta8,9-isomer, EPA considered exposure
under the petitioned-for tolerances as
well as all existing avermectin B1 and its
delta-8,9-isomer tolerances in (40 CFR
180.449). EPA assessed dietary
exposures from avermectin B1 and its
delta-8,9-isomer in food as follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1–day or single
exposure.
In estimating acute dietary exposure,
EPA used food consumption
information from the United States
Department of Agriculture (USDA)
1994–1996 and 1998 Nationwide
Continuing Surveys of Food Intake by
Individuals (CSFII). As to residue levels
in food, EPA used a probabilistic
distribution of anticipated residues
derived from field trial data for all
commodities. Default processing factors
and maximum surveyed percent crop
treated (PCT) were used as available.
See Unit C.1.iv. below for full listing of
PCTs.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the food consumption data
from the USDA 1994–1996 and 1998
CSFII. As to residue levels in food, EPA
E:\FR\FM\07AUR1.SGM
07AUR1
pwalker on DSK8KYBLC1PROD with RULES
39548
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
used point estimates of anticipated
residues derived from field trial data for
all commodities. Default processing
factors and average surveyed percent
crop treated (PCT) were used as
available. Also, residues of avermectin
B1 and its delta-8,9-isomer in foods
exposed in a food-handling
establishment were assumed to be
0.0002 ppm which is one-half the Limit
of Detection (LOD). See Unit C.1.iv.
below for full listing of PCTs.
iii. Cancer. Based on the absence of a
significant increase in tumor incidence
in two rodent studies, EPA classified
avermectin B1 as ‘‘not likely to be
carcinogenic to humans’’ and, thus, an
exposure assessment for evaluating
cancer risk is unnecessary.
iv. Anticipated residue and percent
crop treated (PCT) information. Section
408(b)(2)(E) of FFDCA authorizes EPA
to use available data and information on
the anticipated residue levels of
pesticide residues in food and the actual
levels of pesticide residues that have
been measured in food. If EPA relies on
such information, EPA must require
pursuant to FFDCA section 408(f)(1)
that data be provided 5 years after the
tolerance is established, modified, or
left in effect, demonstrating that the
levels in food are not above the levels
anticipated. For the present action, EPA
will issue such data call-ins as are
required by FFDCA section 408(b)(2)(E)
and authorized under FFDCA section
408(f)(1). Data will be required to be
submitted no later than 5 years from the
date of issuance of these tolerances.
Section 408(b)(2)(F) of FFDCA states
that the Agency may use data on the
actual percent of food treated for
assessing chronic dietary risk only if:
• Condition a: The data used are
reliable and provide a valid basis to
show what percentage of the food
derived from such crop is likely to
contain the pesticide residue.
• Condition b: The exposure
estimate does not underestimate
exposure for any significant
subpopulation group.
• Condition c: Data are available on
pesticide use and food consumption in
a particular area, the exposure estimate
does not understate exposure for the
population in such area.
In addition, the Agency must provide
for periodic evaluation of any estimates
used. To provide for the periodic
evaluation of the estimate of PCT as
required by FFDCA section 408(b)(2)(F),
EPA may require registrants to submit
data on PCT.
The Agency used PCT information as
follows (average and maximum,
respectively):
VerDate Nov<24>2008
15:59 Aug 06, 2009
Jkt 217001
Commodity
Percent Crop Treated
(PCT)
Average
Almond
Maximum
50
75
5
10
Avocado
40
60
Cantaloupe
15
30
Celery
40
65
Cottonseed oil
5
5
Cucumber
5
10
Grape
5
15
Grape, raisin
5
15
Grapefruit
60
80
Honeydew
15
30
Hop
85
100
Lemon
30
50
Lettuce
10
15
Orange
20
40
Pear
65
80
Pepper
25
100
Potato
1
2.5
Pumpkin
2.5
5
Spinach
20
45
Squash
5
10
Strawberry
35
45
Tangerine
40
45
Tomato
15
100
Walnut
5
20
Watermelon
5
10
Apple
EPA assumed 100 PCT (both average
and maximum) for other crops not listed
above, and for all livestock
commodities. Maximum PCT was used
for analysis of acute exposure while
average PCT was used for analysis of
chronic exposure.
In most cases, EPA uses available data
from the U.S. Department of
Agriculture/National Agricultural
Statistics Service (USDA/NASS),
proprietary market surveys, and the
National Pesticide Use Database for the
chemical/crop combination for the most
recent 6 years. EPA uses an average PCT
for chronic dietary risk analysis. The
average PCT figure for each existing use
is derived by combining available
public and private market survey data
PO 00000
Frm 00014
Fmt 4700
Sfmt 4700
for that use, averaging across all
observations, and rounding to the
nearest 5%, except for those situations
in which the average PCT is <1. In those
cases, 1% is used as the average PCT
and 2.5% is used as the maximum PCT.
EPA uses a maximum PCT for acute
dietary risk analysis. The maximum
PCT figure is the highest observed
maximum value reported within the
recent 6 years of available public and
private market survey data for the
existing use and rounded up to the
nearest multiple of 5%.
The Agency believes that the three
conditions discussed in Unit III.C.1.iv.
have been met. With respect to
Condition a, PCT estimates are derived
from Federal and private market survey
data, which are reliable and have a valid
basis. The Agency is reasonably certain
that the percentage of the food treated
is not likely to be an underestimation.
As to Conditions b and c, regional
consumption information and
consumption information for significant
subpopulations is taken into account
through EPA’s computer-based model
for evaluating the exposure of
significant subpopulations including
several regional groups. Use of this
consumption information in EPA’s risk
assessment process ensures that EPA’s
exposure estimate does not understate
exposure for any significant
subpopulation group and allows the
Agency to be reasonably certain that no
regional population is exposed to
residue levels higher than those
estimated by the Agency. Other than the
data available through national food
consumption surveys, EPA does not
have available reliable information on
the regional consumption of food to
which avermectin B1 may be applied in
a particular area.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
exposure analysis and risk assessment
for avermectin B1 and its major soil
degradate (a mixture of an 8-alphahydroxy and a ring opened aldehyde
derivative) in drinking water. These
simulation models take into account
data on the physical, chemical, and fate/
transport characteristics of avermectin
B1 and its major soil degradate (a
mixture of an 8-alpha-hydroxy and a
ring opened aldehyde derivative).
Further information regarding EPA
drinking water models used in pesticide
exposure assessment can be found at
https://www.epa.gov/oppefed1/models/
water/index.htm.
Based on the Pesticide Root Zone
Model/Exposure Analysis Modeling
System (PRZM/EXAMS) for surface
water and Screening Concentration in
E:\FR\FM\07AUR1.SGM
07AUR1
pwalker on DSK8KYBLC1PROD with RULES
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
Ground Water (SCI-GROW) models for
ground water, the estimated drinking
water concentrations (EDWCs) of
avermectin B1 and its major soil
degradate (a mixture of an 8-alphahydroxy and a ring opened aldehyde
derivative) for acute exposures are
estimated to be 0.464 parts per billion
(ppb) for surface water and 0.00184 ppb
for ground water; and for chronic
exposures for non-cancer assessments
are estimated to be 0.211 ppb for surface
water and 0.00184 ppb for ground
water.
Modeled estimates of drinking water
concentrations were directly entered
into the dietary exposure model. For
acute dietary risk assessment, the water
concentration value of 0.464 ppb was
used to assess the contribution to
drinking water. For chronic dietary risk
assessment, the water concentration of
value 0.211 ppb was used to assess the
contribution to drinking water.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Avermectin B1 is currently registered
for the following uses that could result
in residential exposures: Residential
lawn application for fire ant control,
and residential indoor crack and crevice
application for cockroaches and ants.
EPA assessed residential exposure as
follows. Exposure and risk estimates for
homeowners applying crack and crevice
baits were estimated using the Standard
Operating Procedure (SOP) for
Residential Exposure Assessments. The
unit exposure from the wettable
powder, open mixing and loading
scenario listed in the SOP for
Residential Exposure Assessments was
used as a surrogate for estimating
dermal and inhalation exposure for an
activity that involves the use of a small
syringe-type duster to make bait
placements along the baseboards and
into cracks and crevices. The method
used for estimating residential
applicator exposure is believed to
produce a high-end estimate of
exposure.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
VerDate Nov<24>2008
15:59 Aug 06, 2009
Jkt 217001
EPA has not found avermectin B1 to
share a common mechanism of toxicity
with any other substances, and
avermectin B1 does not appear to
produce a toxic metabolite produced by
other substances. For the purposes of
this tolerance action, therefore, EPA has
assumed that avermectin B1 does not
have a common mechanism of toxicity
with other substances. For information
regarding EPA’s efforts to determine
which chemicals have a common
mechanism of toxicity and to evaluate
the cumulative effects of such
chemicals, see EPA’s website at https://
www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(c) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
FQPA safety factor (SF). In applying this
provision, EPA either retains the default
value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
2. Prenatal and postnatal sensitivity.
Increased susceptibility was seen in
prenatal developmental toxicity studies
in mice and rabbits following in utero
exposure to avermectin B1. There was
also an increase in susceptibility in the
rat reproductive toxicity study and the
rat developmental neurotoxicity study.
3. Conclusion. EPA has retained an
additional FQPA SF for chronic/longterm and short/intermediate-term
assessments due to the steepness of the
dose-response curve and severity of
effects (death) at the LOAEL. For all risk
assessments involving repeat exposures,
the selected toxicity endpoint is based
on the decrease in pup body weight
seen in the developmental neurotoxicity
study and three reproduction studies in
the rat. Although the study identified a
NOAEL for the effects observed in the
pups, the data clearly indicate that the
decrease in pup body weight seen at 0.2
mg/kg/day rapidly progresses to death at
the next higher tested dose level (0.4
mg/kg/day) in both reproduction and
developmental neurotoxicity studies.
The combined data from several
reproduction toxicity and
developmental neurotoxicity studies
have documented a very narrow dose
range from NOAEL (0.12 mg/kg/day) to
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
39549
adverse effect (0.2 mg/kg/day) to severe
adverse effect (0.4 mg/kg/day). Dose
spacing is commonly greater than the 2x
between NOAEL and LOAEL here, and
the 3x difference between the NOAEL
and the dose that induced mortality in
the pups in the developmental
neurotoxicity study provides little
margin of safety for such a severe effect.
Nonetheless, EPA has determined that
reliable data show the safety of infants
and children would be adequately
protected if the 10X FQPA safety (SF)
were reduced to 3X for chronic/long
term and short/intermediate-term
assessments and reduced to 1X for acute
assessments. This conclusion is based
on the following findings:
i. Retaining an additional 3x FQPA
safety factor effectively provides a 10x
margin between the dose which causes
death (0.4 mg/kg/day) and the NOAEL
adjusted by the additional safety factor
(0.12 mg/kg/day/3x = 0.04 mg/kg/day).
A dose spacing of 10x between a
NOAEL and LOAEL is as broad, if not
broader, than the dose spacing generally
used in animal testing and thus removes
the residual concern with the steepness
of the dose response curve and the
severe effects seen here.
ii. This adjusted point of departure
(0.04 mg/kg/day) would also address the
concerns for the increased susceptibility
seen at higher doses in the twogeneration reproduction study in rats
(LOAEL = 0.4 mg/kg/day), prenatal
developmental study in CD-1 mice
(LOAEL = 0.75 mg/kg/day), the prenatal
developmental toxicity study in rabbits
(LOAEL = 2 mg/kg/day), and the onegeneration reproduction study (LOAEL
= 0.2 mg/kg/day).
iii. The toxicity database for
avermectin B1 is complete, except for
immunotoxicity studies. EPA began
requiring functional immunotoxicity
testing of all food and non-food use
pesticides on December 26, 2007. To
address the issue of an immunotoxicity
data gap and the associated database
uncertainty factor, the Agency examined
the entire database of avermectin B1 and
determined that an additional
uncertainty factor is not needed to
account for potential immunotoxicity.
Avermectin B1 has not been found to
induce effects associated with
immunotoxicity and avermectin B1 does
not belong to a class of chemicals that
would be expected to be immunotoxic.
Therefore, based on the above
considerations, EPA does not believe
that conducting a special Harmonized
Guideline series 870.7800
immunotoxicity study will result in a
NOAEL less than the NOAELs of 0.5
and 0.12 mg/kg/day already set for
avermectin B1 acute and repeated
E:\FR\FM\07AUR1.SGM
07AUR1
39550
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
pwalker on DSK8KYBLC1PROD with RULES
exposures, respectively. An additional
uncertainty factor (UFDB) for database
uncertainties associated with
immunotoxicity does not need to be
applied at this time.
iv. With respect to acute dietary
exposure, the endpoint selected for risk
assessment is based on mydriasis
observed in dogs. The additional 3x
factor applied to chronic and other
exposure scenarios is not applicable to
acute exposure because steepness of the
dose and severity of effects were not
seen in the studies where mydriasis
occurred. In addition, reduced body
weight is not considered a single dose
effect and would not be appropriate as
a toxicity endpoint for acute exposure
scenarios.
v. There are no residual concerns with
respect to the exposure databases. The
chronic and acute dietary food exposure
assessment utilizes reliable data on
anticipated residues and percent crop
treated as well as default processing
factors. The dietary drinking water
assessment utilized modeling results
which included conservative
assumptions for the parent and all
degradates of concern. Conservative
assumptions were used in the water
models. Therefore, the water exposure
assessment will not underestimate the
potential risks for infants and children.
Likewise, the use of maximum
application rates and central-to-high
end inputs results in calculated
residential exposures that should not
underestimate the risks to infants and
children from these requested uses.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic pesticide exposures are safe by
comparing aggregate exposure estimates
to the acute population adjusted dose
(aPAD) and chronic population adjusted
dose (cPAD). The aPAD and cPAD
represent the highest safe exposures,
taking into account all appropriate SFs.
EPA calculates the aPAD and cPAD by
dividing the POD by all applicable UFs.
For linear cancer risks, EPA calculates
the probability of additional cancer
cases given the estimated aggregate
exposure. Short-, intermediate-, and
chronic-term risks are evaluated by
comparing the estimated aggregate food,
water, and residential exposure to the
POD to ensure that the MOE called for
by the product of all applicable UFs is
not exceeded.
1. Acute risk. The acute aggregate risk
assessment takes into account exposure
from dietary (food and water)
consumption. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
VerDate Nov<24>2008
15:59 Aug 06, 2009
Jkt 217001
exposure from food and water to
avermectin B1 and its delta-8,9-isomer
will occupy 27% of the aPAD for
children 1 to 2 years old, the population
group receiving the greatest exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to avermectin B1
and its delta-8,9-isomer from food and
water will utilize 47% of the cPAD for
children 1 to 2 years old, the population
group receiving the greatest exposure.
Based on the explanation in Unit
III.C.3., regarding residential use
patterns, chronic residential exposure to
residues of avermectin B1 and its delta8,9-isomer is not expected.
3. Short- and intermediate-term risk.
Short- and intermediate-term aggregate
exposure takes into account short-term
residential exposure plus chronic
exposure to food and water (considered
to be a background exposure level).
High-end estimates of residential
exposure were used, while average
values were used for food and drinking
water exposure. Avermectin B1 is
currently registered for uses that could
result in short- and intermediate-term
residential exposure and the Agency has
determined that it is appropriate to
aggregate chronic exposure through food
and water with short- and intermediateterm residential exposures to
avermectin B1 and its delta-8,9-isomer.
Using the exposure assumptions
described in this unit for short-term
exposures, EPA has concluded the
combined short- and intermediate-term
food, water, and residential exposures
result in aggregate MOEs of 500 for
children 1 to 2 years old, the population
group receiving the greatest exposure.
4. Aggregate cancer risk for U.S.
population. Based on the absence of a
significant increase in tumor incidence
in two rodent studies, EPA classified
avermectin B1 as ‘‘not likely to be
carcinogenic to humans’’ and it is,
therefore, not expected to pose a cancer
risk.
5. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population or to infants and children
from aggregate exposure to avermectin
B1 and its delta-8,9-isomer residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methods for
avermectin B1 in plant and livestock
commodities are available in PAM II.
The methods have been validated for
citrus and processed fractions (Method
I), ginned cottonseed (Method IA), and
PO 00000
Frm 00016
Fmt 4700
Sfmt 4700
bovine tissues and milk (Method II).
These methods determine residues in
plant and livestock commodities at
limits of quantitation of 0.02 ppm for
meat and meat byproducts and ≤0.01
ppm for other plant/livestock
commodities. The limits of detection of
the methods for plant and livestock
commodities is 0.001 ppm for each
analyte, equivalent to 0.002 ppm for two
analyte peaks (i.e., avermectin B1a and
its delta-8,9-isomer in one peak and
avermectin B1b and its delta-8,9-isomer
in the other peak).
The plant methods used for data
collection adequately measure the
residues of concern. The methods have
been validated at 0.001, 0.002, or 0.005
ppm (depending on the commodity and
the method) for each of two analyte
peaks (avermectin B1a and its delta-8,9isomer in one peak and avermectin B1b
and its delta-8,9-isomer in the other
peak), which means that the LOQs of
the data collection methods would be
0.002, 0.004 or 0.01 ppm.
The 1990 Pestrak database indicates
that avermectin B1 and its metabolites
are not recovered or not likely to be
recovered by FDA multiresidue
methods. Therefore, the multiresidue
methods can not be used to determine
residues for dietary exposure
assessment and can not be used as the
primary enforcement method.
B. International Residue Limits
The Codex tolerance expressions for
plants are consistent with the U.S.
tolerance expression.
C. Response to Comments
No comments were received to the
Notices of Filing.
D. Revisions to Petitioned-For
Tolerances
The correct commodity definitions are
obtained from the ‘‘Food and Feed
Commodity Vocabulary’’, which can be
found at https://www.epa.gov/pesticides/
foodfeed. Some proposed tolerance
levels were raised based on EPA’s
analysis of the residue data, EPA’s
assessment of the limits of quantitation
of the analytical methods, current
livestock feed items (OPPTS Guideline
860.100, Table 1 Feedstuffs, June 2008),
and/or to coordinate with Codex
Maximum Residue Limits (MRLs).
V. Conclusion
Therefore, tolerances are established
for combined residues of avermectin B1
(a mixture of avermectins containing
greater than or equal to 80% avermectin
B1a (5-O-demethyl avermectin A1) and
less than or equal to 20% avermectin
B1b (5-O-demethyl-25-de (1-
E:\FR\FM\07AUR1.SGM
07AUR1
Federal Register / Vol. 74, No. 151 / Friday, August 7, 2009 / Rules and Regulations
pwalker on DSK8KYBLC1PROD with RULES
methylpropyl)-25-(1-methylethyl)
avermectin A1)), and its delta-8,9-isomer
in/on cattle, fat at 0.03 ppm; cattle, meat
byproducts at 0.06 ppm; fruit, stone,
group 12 at 0.09 ppm; goat, fat at 0.01
ppm; hog, fat at 0.01 ppm; horse, fat at
0.01 ppm; nut, tree, group 14 at 0.01
ppm; pistachio at 0.01 ppm; sheep, fat
at 0.01 ppm; and vegetable, tuberous
and corm subgroup 01C at 0.01 ppm.
Existing tolerances for cattle, fat and
cattle, meat byproducts are revised.
Existing individual crop tolerances on
almond, plum, potato, and walnut are
deleted and replaced by the
establishment of new crop group
tolerances. Existing tolerances on
almond, hulls and plum, prune, dried
are retained. The expression for existing
mint tolerances is corrected by deleting
the term mint and replacing with
peppermint, tops at 0.010 ppm and
spearmint, tops at 0.010 ppm.
VI. Statutory and Executive Order
Reviews
This final rule establishes tolerances
under section 408(d) of FFDCA in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled Regulatory
Planning and Review (58 FR 51735,
October 4, 1993). Because this final rule
has been exempted from review under
Executive Order 12866, this final rule is
not subject to Executive Order 13211,
entitled Actions Concerning Regulations
That Significantly Affect Energy Supply,
Distribution, or Use (66 FR 28355, May
22, 2001) or Executive Order 13045,
entitled Protection of Children from
Environmental Health Risks and Safety
Risks (62 FR 19885, April 23, 1997).
This final rule does not contain any
information collections subject to OMB
approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et
seq., nor does it require any special
considerations under Executive Order
12898, entitled Federal Actions to
Address Environmental Justice in
Minority Populations and Low-Income
Populations (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under section 408(d) of FFDCA, such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates
growers, food processors, food handlers,
and food retailers, not States or tribes,
nor does this action alter the
relationships or distribution of power
VerDate Nov<24>2008
15:59 Aug 06, 2009
Jkt 217001
and responsibilities established by
Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such,
the Agency has determined that this
action will not have a substantial direct
effect on States or tribal governments,
on the relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
Federalism (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled Consultation and Coordination
with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply
to this final rule. In addition, this final
rule does not impose any enforceable
duty or contain any unfunded mandate
as described under Title II of the
Unfunded Mandates Reform Act of 1995
(UMRA) (Public Law 104–4).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act of 1995
(NTTAA), Public Law 104–113, section
12(d) (15 U.S.C. 272 note).
VII. Congressional Review Act
The Congressional Review Act, 5
U.S.C. 801 et seq., generally provides
that before a rule may take effect, the
agency promulgating the rule must
submit a rule report to each House of
the Congress and to the Comptroller
General of the United States. EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of this final rule in the
Federal Register. This final rule is not
a ‘‘major rule’’ as defined by 5 U.S.C.
804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: July 28, 2009.
Lois Rossi,
Director, Registration Division, Office of
Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
■
PO 00000
Frm 00017
Fmt 4700
Sfmt 4700
39551
PART 180—AMENDED
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In § 180.449, the table to paragraph
(a) is amended by revising the entries
for cattle, fat and cattle, meat
byproducts; by removing the entries for
almond, plum, mint, potato and walnut;
and by adding alphabetically, the
remaining entries in the table to read as
follows:
■
180.449 Avermectin B1 and its delta-8,9isomer; tolerances for residues.
(a) *
*
*
Commodity
Parts per
million
*
*
*
*
Cattle, fat ......................................
Cattle, meat byproducts ...............
*
*
*
*
Fruit, stone, group 12 ...................
Goat, fat ........................................
*
*
*
*
Hog, fat .........................................
*
*
*
*
Horse, fat ......................................
*
*
*
*
Nut, tree, group 14 .......................
*
*
*
*
Peppermint, tops ..........................
Pistachio .......................................
*
*
*
*
Sheep, fat .....................................
*
*
*
*
Spearmint, tops ............................
Vegetable, tuberous and corm,
subgroup 01C ...........................
*
*
*
*
*
0.03
0.06
*
0.09
0.01
*
0.01
*
0.01
*
0.01
*
0.010
0.01
*
0.01
*
0.010
0.01
*
FR Doc. E9–19006 Filed 8–6–09; 8:45 am
BILLING CODE 6560–50–S
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Part 63
[WC Docket No. 04–36; FCC 09–40]
IP-Enabled Services
AGENCY: Federal Communications
Commission.
ACTION: Final rule.
SUMMARY: This document amends the
Commission’s rules so that providers of
interconnected Voice over Internet
Protocol (VoIP) service will be required
to comply with the same discontinuance
rules as domestic non-dominant
telecommunications carriers. These
rules protect consumers of
interconnected VoIP service from the
abrupt discontinuance, reduction or
impairment of their service by requiring
E:\FR\FM\07AUR1.SGM
07AUR1
Agencies
[Federal Register Volume 74, Number 151 (Friday, August 7, 2009)]
[Rules and Regulations]
[Pages 39545-39551]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-19006]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2008-0806; FRL-8427-7]
Avermectin B1 and its delta-8,9-isomer; Pesticide
Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for combined residues
of avermectin B1 and its delta-8,9-isomer in or on stone
fruit crop group 12, tree nut crop group 14, pistachio, tuberous and
corm vegetable crop subgroup 01C, goat fat, hog fat, horse fat, sheep
fat, cattle fat, and cattle meat byproducts. Existing tolerances for
cattle, fat and cattle, meat byproducts are revised. Existing
individual crop tolerances on almond, plum, potato, and walnut are
deleted and replaced by the establishment of new crop group tolerances.
Existing tolerances on almond, hulls and plum, prune, dried are
retained. This regulation also makes a technical correction to
correctly express the existing tolerances for mint (replace term
``mint'' with the more specific terms ``peppermint, tops'' and
``spearmint, tops''). Syngenta Crop Protection, Inc. and Y-TEX
Corporation requested these tolerances under the Federal Food, Drug,
and Cosmetic Act (FFDCA).
DATES: This regulation is effective August 7, 2009. Objections and
requests for hearings must be received on or before October 6, 2009,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: EPA has established a docket for this action under docket
identification (ID) number EPA-HQ-OPP-2008-0806. All documents in the
docket are listed in the docket index available at https://
www.regulations.gov. Although listed in the index, some information is
not publicly available, e.g., Confidential Business Information (CBI)
or other information whose disclosure is restricted by statute. Certain
other material, such as copyrighted material, is not placed on the
Internet and will be publicly available only in hard copy form.
Publicly available docket materials are available in the electronic
docket at https://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The Docket
Facility is open from 8:30 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket Facility telephone number is (703)
305-5805.
FOR FURTHER INFORMATION CONTACT: Thomas C. Harris, Registration
Division (7505P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number: (703) 308-9423; e-mail address:
harris.thomas@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this Action Apply to Me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
Potentially affected entities may include, but are not limited to those
engaged in the following activities:
[[Page 39546]]
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
This listing is not intended to be exhaustive, but rather to
provide a guide for readers regarding entities likely to be affected by
this action. Other types of entities not listed in this unit could also
be affected. The North American Industrial Classification System
(NAICS) codes have been provided to assist you and others in
determining whether this action might apply to certain entities. If you
have any questions regarding the applicability of this action to a
particular entity, consult the person listed under FOR FURTHER
INFORMATION CONTACT.
B. How Can I Access Electronic Copies of this Document?
In addition to accessing electronically available documents at
https://www.regulations.gov, you may access this Federal Register
document electronically through the EPA Internet under the ``Federal
Register'' listings at https://www.epa.gov/fedrgstr. You may also access
a frequently updated electronic version of EPA's tolerance regulations
at 40 CFR part 180 through the Government Printing Office's e-CFR cite
at https://www.gpoaccess.gov/ecfr. To access the OPPTS Harmonized
Guidelines referenced in this document, go directly to the guidelines
at https://www.epa.gov/opptsfrs/home/guidelin.htm.
C. Can I File an Objection or Hearing Request?
Under section 408(g) of FFDCA, 21 U.S.C. 346a, any person may file
an objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2008-0806 in the subject line on the first
page of your submission. All requests must be in writing, and must be
mailed or delivered to the Hearing Clerk as required by 40 CFR part 178
on or before October 6, 2009.
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing that does not contain any CBI for inclusion in the public
docket that is described in ADDRESSES. Information not marked
confidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA
without prior notice. Submit this copy, identified by docket ID number
EPA-HQ-OPP-2008-0806, by one of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is (703) 305-5805.
II. Petition for Tolerance
As listed below, EPA published notices pursuant to section
408(d)(3) of FFDCA, 21 U.S.C. 346a(d)(3), announcing the filing of
pesticide petitions in the Federal Register requesting that 40 CFR
180.449 be amended by establishing a tolerance for combined residues of
the insecticide/miticide avermectin B1 (a mixture of
avermectins containing greater than or equal to 80% avermectin
B1a (5-O-demethyl avermectin A1) and less than or
equal to 20% avermectin B1b (5-O-demethyl-25-de (1-
methylpropyl)-25-(1-methylethyl) avermectin A1)), and its
delta-8,9-isomer, as listed below. Avermectin B1 is also
referred to as abamectin. Each notice included a summary of the
petition prepared by the registrant listed. There were no comments
received in response to these notices of filing.
September 27, 2000, 65 FR 58080, FRL-6746-4, PP 0F6146. This
petition was filed by Novartis Crop Protection, Inc. (now Syngenta Crop
Protection, Inc.), P.O. Box 18300, Greensboro, NC 27419-8300 for
tolerances of avermectin B1 and its delta-8,9-isomer in or
on grass forage at 0.001 ppm, grass hay at 0.001 ppm, stone fruit crop
group 12 at 0.015 ppm, tree nut crop group 14 at 0.005 ppm, pistachio
at 0.005 ppm, and the tuberous and corm vegetable crop subgroup 01C at
0.005 ppm. Tolerances for avocado and mint which were also requested in
that notice were established earlier (see February 16, 2005, 70 FR
7876).
Based upon EPA review of the data supporting the petition, the
petition was subsequently amended to request permanent tolerances for
avermectin B1 and its delta-8,9-isomer at the revised levels
as follow: Stone fruit crop group 12 at 0.09 ppm, tree nut crop group
14 at 0.01 ppm, pistachios at 0.01 ppm, tuberous and corm vegetables
crop subgroup 01C at 0.01 ppm, goat fat at 0.01 ppm, hog fat at 0.01
ppm, horse fat at 0.01 ppm, and sheep fat at 0.01 ppm. The tolerance
requests for grass hay and grass forage were withdrawn pending
development of further data on grass hay. Existing individual crop
tolerances on almond, plum, potato, and walnut are deleted and replaced
by the establishment of new crop group tolerances. Existing tolerances
on almond, hulls and plum, prune, dried are retained. The proposed
tolerance levels were raised based on EPA's analysis of the residue
data, EPA's assessment of the limits of quantitation (LOQs) of the
analytical methods, current livestock feed items (OPPTS Guideline
860.100, Table 1 Feedstuffs, June 2008), and/or to coordinate with
Codex Maximum Residue Limits (MRLs) (see Unit IV.B.).
December 3, 2008, 73 FR 73648, FRL-8391-3, PP 8F7454. This petition
was filed by Y-TEX Corporation, 1825 Big Horn Avenue, P.O. Box 1450,
Cody, WY 82414, and proposes to amend the tolerances in 40 CFR 180.449
by increasing the tolerances of avermectin B1 and its delta-
8,9-isomer in or on cattle fat from 0.015 ppm to 0.03 ppm and cattle
meat byproducts from 0.02 ppm to 0.06 ppm. These tolerances support use
of avermectin in cattle ear tags.
This regulation also makes a technical amendment to correctly
express the existing tolerances for mint which were established in the
final rule published on February 16, 2005 (70 FR 7876) (FRL-7695-7).
That rule listed the tolerance as ``mint'' at 0.010 ppm. The correct
terminology is ``peppermint, tops'' at 0.010 ppm and ``spearmint,
tops'' at 0.010 ppm.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is
[[Page 39547]]
reliable information.'' This includes exposure through drinking water
and in residential settings, but does not include occupational
exposure. Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical
residue....''
Consistent with section 408(b)(2)(D) of FFDCA, and the factors
specified in section 408(b)(2)(D) of FFDCA, EPA has reviewed the
available scientific data and other relevant information in support of
this action. EPA has sufficient data to assess the hazards of and to
make a determination on aggregate exposure for the petitioned-for
tolerances for combined residues of avermectin B1 and its
delta-8,9-isomer on stone fruit crop group 12 at 0.09 ppm, tree nut
crop group 14 at 0.01 ppm, pistachios at 0.01 ppm, tuberous and corm
vegetables crop subgroup 01C at 0.01 ppm, goat fat at 0.01 ppm, hog fat
at 0.01 ppm, horse fat at 0.01 ppm, sheep fat at 0.01 ppm, cattle fat
at 0.03 ppm, and cattle meat byproducts at 0.06 ppm. EPA's assessment
of exposures and risks associated with establishing tolerances follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
Avermection B1 (also known as abamectin) has high to
moderate acute toxicity by the oral route, high acute toxicity by the
inhalation route, and low acute toxicity by the dermal route. It is
slightly irritating to the skin, but is not an ocular irritant or a
dermal sensitizer. In general, the results of available toxicity
studies with single or repeated dosing indicate that the main target
organ for avermection B1 is the nervous system, and that
decreased body weight is also one of the most frequent findings. There
was no observed estrogen, androgen, or thyroid mediated toxicity.
Neurotoxicity and developmental effects are detected in multiple
studies and species of test animals. The dose/response curve is very
steep in several studies, with severe effects (including death and
morbid sacrifice) seen at dose levels as low as 0.4 milligrams/
kilogram/day (mg/kg/day) and 0.1 mg/kg/day in rats and mice,
respectively, following repeated exposures. Increased susceptibility
(qualitative and/or quantitative) was seen in prenatal developmental
toxicity studies in mice and rabbits, and an increase in quantitative
and qualitative susceptibility was also seen in the rat reproductive
toxicity studies. Review of acceptable oncogenicity and mutagenicity
studies provide no indication that avermection B1 is
carcinogenic or mutagenic.
Specific information on the studies received and the nature of the
adverse effects caused by avermectin B1 and its delta-8,9-
isomer as well as the no-observed-adverse-effect-level (NOAEL) and the
lowest-observed-adverse-effect-level (LOAEL) from the toxicity studies
can be found at https://www.regulations.gov in document the ``Abamectin,
Revised Human Health Risk Assessment for Proposed Uses on Pasture and
Rangeland Grass, Stone Fruit Crop Group 12, Tree Nut Crop Group 14,
Pistachio, Tuberous and Corm Vegetables Subgroup 01C, and Request for
Cattle Ear Tag Use,'' at page 18 in docket ID number EPA-HQ-OPP-2008-
0806.
B. Toxicological Endpoints
For hazards that have a threshold below which there is no
appreciable risk, a toxicological point of departure (POD) is
identified as the basis for derivation of reference values for risk
assessment. The POD may be defined as the highest dose at which no
adverse effects are observed (the NOAEL) in the toxicology study
identified as appropriate for use in risk assessment. However, if a
NOAEL cannot be determined, the lowest dose at which adverse effects of
concern are identified (the LOAEL) or a Benchmark Dose (BMD) approach
is sometimes used for risk assessment. Uncertainty/safety factors (UFs)
are used in conjunction with the POD to take into account uncertainties
inherent in the extrapolation from laboratory animal data to humans and
in the variations in sensitivity among members of the human population
as well as other unknowns. Safety is assessed for acute and chronic
dietary risks by comparing aggregate food and water exposure to the
pesticide to the acute population adjusted dose (aPAD) and chronic
population adjusted dose (cPAD). The aPAD and cPAD are calculated by
dividing the POD by all applicable UFs. Aggregate short-, intermediate-
, and chronic-term risks are evaluated by comparing food, water, and
residential exposure to the POD to ensure that the margin of exposure
(MOE) called for by the product of all applicable UFs is not exceeded.
This latter value is referred to as the Level of Concern (LOC).
For non-threshold risks, the Agency assumes that any amount of
exposure will lead to some degree of risk. Thus, the Agency estimates
risk in terms of the probability of an occurrence of the adverse effect
greater than that expected in a lifetime. For more information on the
general principles EPA uses in risk characterization and a complete
description of the risk assessment process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm.
A summary of the toxicological endpoints for avermectin
B1 and its delta-8,9-isomer used for human risk assessment
can be found at https://www.regulations.gov in the document ``Abamectin,
Revised Human Health Risk Assessment for Proposed Uses on Pasture and
Rangeland Grass, Stone Fruit Crop Group 12, Tree Nut Crop Group 14,
Pistachio, Tuberous and Corm Vegetables Subgroup 01C, and Request for
Cattle Ear Tag Use,'' at page 25 in docket ID number EPA-HQ-OPP-2008-
0806.
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to avermectin B1 and its delta-8,9-isomer, EPA
considered exposure under the petitioned-for tolerances as well as all
existing avermectin B1 and its delta-8,9-isomer tolerances
in (40 CFR 180.449). EPA assessed dietary exposures from avermectin
B1 and its delta-8,9-isomer in food as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure.
In estimating acute dietary exposure, EPA used food consumption
information from the United States Department of Agriculture (USDA)
1994-1996 and 1998 Nationwide Continuing Surveys of Food Intake by
Individuals (CSFII). As to residue levels in food, EPA used a
probabilistic distribution of anticipated residues derived from field
trial data for all commodities. Default processing factors and maximum
surveyed percent crop treated (PCT) were used as available. See Unit
C.1.iv. below for full listing of PCTs.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the USDA 1994-1996
and 1998 CSFII. As to residue levels in food, EPA
[[Page 39548]]
used point estimates of anticipated residues derived from field trial
data for all commodities. Default processing factors and average
surveyed percent crop treated (PCT) were used as available. Also,
residues of avermectin B1 and its delta-8,9-isomer in foods
exposed in a food-handling establishment were assumed to be 0.0002 ppm
which is one-half the Limit of Detection (LOD). See Unit C.1.iv. below
for full listing of PCTs.
iii. Cancer. Based on the absence of a significant increase in
tumor incidence in two rodent studies, EPA classified avermectin
B1 as ``not likely to be carcinogenic to humans'' and, thus,
an exposure assessment for evaluating cancer risk is unnecessary.
iv. Anticipated residue and percent crop treated (PCT) information.
Section 408(b)(2)(E) of FFDCA authorizes EPA to use available data and
information on the anticipated residue levels of pesticide residues in
food and the actual levels of pesticide residues that have been
measured in food. If EPA relies on such information, EPA must require
pursuant to FFDCA section 408(f)(1) that data be provided 5 years after
the tolerance is established, modified, or left in effect,
demonstrating that the levels in food are not above the levels
anticipated. For the present action, EPA will issue such data call-ins
as are required by FFDCA section 408(b)(2)(E) and authorized under
FFDCA section 408(f)(1). Data will be required to be submitted no later
than 5 years from the date of issuance of these tolerances.
Section 408(b)(2)(F) of FFDCA states that the Agency may use data
on the actual percent of food treated for assessing chronic dietary
risk only if:
Condition a: The data used are reliable and provide a
valid basis to show what percentage of the food derived from such crop
is likely to contain the pesticide residue.
Condition b: The exposure estimate does not underestimate
exposure for any significant subpopulation group.
Condition c: Data are available on pesticide use and food
consumption in a particular area, the exposure estimate does not
understate exposure for the population in such area.
In addition, the Agency must provide for periodic evaluation of any
estimates used. To provide for the periodic evaluation of the estimate
of PCT as required by FFDCA section 408(b)(2)(F), EPA may require
registrants to submit data on PCT.
The Agency used PCT information as follows (average and maximum,
respectively):
------------------------------------------------------------------------
Percent Crop Treated
(PCT)
Commodity ---------------------
Average Maximum
------------------------------------------------------------------------
Almond 50 75
------------------------------------------------------------------------
Apple 5 10
------------------------------------------------------------------------
Avocado 40 60
------------------------------------------------------------------------
Cantaloupe 15 30
------------------------------------------------------------------------
Celery 40 65
------------------------------------------------------------------------
Cottonseed oil 5 5
------------------------------------------------------------------------
Cucumber 5 10
------------------------------------------------------------------------
Grape 5 15
------------------------------------------------------------------------
Grape, raisin 5 15
------------------------------------------------------------------------
Grapefruit 60 80
------------------------------------------------------------------------
Honeydew 15 30
------------------------------------------------------------------------
Hop 85 100
------------------------------------------------------------------------
Lemon 30 50
------------------------------------------------------------------------
Lettuce 10 15
------------------------------------------------------------------------
Orange 20 40
------------------------------------------------------------------------
Pear 65 80
------------------------------------------------------------------------
Pepper 25 100
------------------------------------------------------------------------
Potato 1 2.5
------------------------------------------------------------------------
Pumpkin 2.5 5
------------------------------------------------------------------------
Spinach 20 45
------------------------------------------------------------------------
Squash 5 10
------------------------------------------------------------------------
Strawberry 35 45
------------------------------------------------------------------------
Tangerine 40 45
------------------------------------------------------------------------
Tomato 15 100
------------------------------------------------------------------------
Walnut 5 20
------------------------------------------------------------------------
Watermelon 5 10
------------------------------------------------------------------------
EPA assumed 100 PCT (both average and maximum) for other crops not
listed above, and for all livestock commodities. Maximum PCT was used
for analysis of acute exposure while average PCT was used for analysis
of chronic exposure.
In most cases, EPA uses available data from the U.S. Department of
Agriculture/National Agricultural Statistics Service (USDA/NASS),
proprietary market surveys, and the National Pesticide Use Database for
the chemical/crop combination for the most recent 6 years. EPA uses an
average PCT for chronic dietary risk analysis. The average PCT figure
for each existing use is derived by combining available public and
private market survey data for that use, averaging across all
observations, and rounding to the nearest 5%, except for those
situations in which the average PCT is <1. In those cases, 1% is used
as the average PCT and 2.5% is used as the maximum PCT. EPA uses a
maximum PCT for acute dietary risk analysis. The maximum PCT figure is
the highest observed maximum value reported within the recent 6 years
of available public and private market survey data for the existing use
and rounded up to the nearest multiple of 5%.
The Agency believes that the three conditions discussed in Unit
III.C.1.iv. have been met. With respect to Condition a, PCT estimates
are derived from Federal and private market survey data, which are
reliable and have a valid basis. The Agency is reasonably certain that
the percentage of the food treated is not likely to be an
underestimation. As to Conditions b and c, regional consumption
information and consumption information for significant subpopulations
is taken into account through EPA's computer-based model for evaluating
the exposure of significant subpopulations including several regional
groups. Use of this consumption information in EPA's risk assessment
process ensures that EPA's exposure estimate does not understate
exposure for any significant subpopulation group and allows the Agency
to be reasonably certain that no regional population is exposed to
residue levels higher than those estimated by the Agency. Other than
the data available through national food consumption surveys, EPA does
not have available reliable information on the regional consumption of
food to which avermectin B1 may be applied in a particular
area.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for avermectin B1 and its major soil degradate (a
mixture of an 8-alpha-hydroxy and a ring opened aldehyde derivative) in
drinking water. These simulation models take into account data on the
physical, chemical, and fate/transport characteristics of avermectin
B1 and its major soil degradate (a mixture of an 8-alpha-
hydroxy and a ring opened aldehyde derivative). Further information
regarding EPA drinking water models used in pesticide exposure
assessment can be found at https://www.epa.gov/oppefed1/models/water/
index.htm.
Based on the Pesticide Root Zone Model/Exposure Analysis Modeling
System (PRZM/EXAMS) for surface water and Screening Concentration in
[[Page 39549]]
Ground Water (SCI-GROW) models for ground water, the estimated drinking
water concentrations (EDWCs) of avermectin B1 and its major
soil degradate (a mixture of an 8-alpha-hydroxy and a ring opened
aldehyde derivative) for acute exposures are estimated to be 0.464
parts per billion (ppb) for surface water and 0.00184 ppb for ground
water; and for chronic exposures for non-cancer assessments are
estimated to be 0.211 ppb for surface water and 0.00184 ppb for ground
water.
Modeled estimates of drinking water concentrations were directly
entered into the dietary exposure model. For acute dietary risk
assessment, the water concentration value of 0.464 ppb was used to
assess the contribution to drinking water. For chronic dietary risk
assessment, the water concentration of value 0.211 ppb was used to
assess the contribution to drinking water.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets).
Avermectin B1 is currently registered for the following
uses that could result in residential exposures: Residential lawn
application for fire ant control, and residential indoor crack and
crevice application for cockroaches and ants. EPA assessed residential
exposure as follows. Exposure and risk estimates for homeowners
applying crack and crevice baits were estimated using the Standard
Operating Procedure (SOP) for Residential Exposure Assessments. The
unit exposure from the wettable powder, open mixing and loading
scenario listed in the SOP for Residential Exposure Assessments was
used as a surrogate for estimating dermal and inhalation exposure for
an activity that involves the use of a small syringe-type duster to
make bait placements along the baseboards and into cracks and crevices.
The method used for estimating residential applicator exposure is
believed to produce a high-end estimate of exposure.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
EPA has not found avermectin B1 to share a common
mechanism of toxicity with any other substances, and avermectin
B1 does not appear to produce a toxic metabolite produced by
other substances. For the purposes of this tolerance action, therefore,
EPA has assumed that avermectin B1 does not have a common
mechanism of toxicity with other substances. For information regarding
EPA's efforts to determine which chemicals have a common mechanism of
toxicity and to evaluate the cumulative effects of such chemicals, see
EPA's website at https://www.epa.gov/pesticides/cumulative.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(c) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the FQPA safety
factor (SF). In applying this provision, EPA either retains the default
value of 10X, or uses a different additional safety factor when
reliable data available to EPA support the choice of a different
factor.
2. Prenatal and postnatal sensitivity. Increased susceptibility was
seen in prenatal developmental toxicity studies in mice and rabbits
following in utero exposure to avermectin B1. There was also
an increase in susceptibility in the rat reproductive toxicity study
and the rat developmental neurotoxicity study.
3. Conclusion. EPA has retained an additional FQPA SF for chronic/
long-term and short/intermediate-term assessments due to the steepness
of the dose-response curve and severity of effects (death) at the
LOAEL. For all risk assessments involving repeat exposures, the
selected toxicity endpoint is based on the decrease in pup body weight
seen in the developmental neurotoxicity study and three reproduction
studies in the rat. Although the study identified a NOAEL for the
effects observed in the pups, the data clearly indicate that the
decrease in pup body weight seen at 0.2 mg/kg/day rapidly progresses to
death at the next higher tested dose level (0.4 mg/kg/day) in both
reproduction and developmental neurotoxicity studies. The combined data
from several reproduction toxicity and developmental neurotoxicity
studies have documented a very narrow dose range from NOAEL (0.12 mg/
kg/day) to adverse effect (0.2 mg/kg/day) to severe adverse effect (0.4
mg/kg/day). Dose spacing is commonly greater than the 2x between NOAEL
and LOAEL here, and the 3x difference between the NOAEL and the dose
that induced mortality in the pups in the developmental neurotoxicity
study provides little margin of safety for such a severe effect.
Nonetheless, EPA has determined that reliable data show the safety
of infants and children would be adequately protected if the 10X FQPA
safety (SF) were reduced to 3X for chronic/long term and short/
intermediate-term assessments and reduced to 1X for acute assessments.
This conclusion is based on the following findings:
i. Retaining an additional 3x FQPA safety factor effectively
provides a 10x margin between the dose which causes death (0.4 mg/kg/
day) and the NOAEL adjusted by the additional safety factor (0.12 mg/
kg/day/3x = 0.04 mg/kg/day). A dose spacing of 10x between a NOAEL and
LOAEL is as broad, if not broader, than the dose spacing generally used
in animal testing and thus removes the residual concern with the
steepness of the dose response curve and the severe effects seen here.
ii. This adjusted point of departure (0.04 mg/kg/day) would also
address the concerns for the increased susceptibility seen at higher
doses in the two-generation reproduction study in rats (LOAEL = 0.4 mg/
kg/day), prenatal developmental study in CD-1 mice (LOAEL = 0.75 mg/kg/
day), the prenatal developmental toxicity study in rabbits (LOAEL = 2
mg/kg/day), and the one-generation reproduction study (LOAEL = 0.2 mg/
kg/day).
iii. The toxicity database for avermectin B1 is
complete, except for immunotoxicity studies. EPA began requiring
functional immunotoxicity testing of all food and non-food use
pesticides on December 26, 2007. To address the issue of an
immunotoxicity data gap and the associated database uncertainty factor,
the Agency examined the entire database of avermectin B1 and
determined that an additional uncertainty factor is not needed to
account for potential immunotoxicity. Avermectin B1 has not
been found to induce effects associated with immunotoxicity and
avermectin B1 does not belong to a class of chemicals that
would be expected to be immunotoxic. Therefore, based on the above
considerations, EPA does not believe that conducting a special
Harmonized Guideline series 870.7800 immunotoxicity study will result
in a NOAEL less than the NOAELs of 0.5 and 0.12 mg/kg/day already set
for avermectin B1 acute and repeated
[[Page 39550]]
exposures, respectively. An additional uncertainty factor
(UFDB) for database uncertainties associated with
immunotoxicity does not need to be applied at this time.
iv. With respect to acute dietary exposure, the endpoint selected
for risk assessment is based on mydriasis observed in dogs. The
additional 3x factor applied to chronic and other exposure scenarios is
not applicable to acute exposure because steepness of the dose and
severity of effects were not seen in the studies where mydriasis
occurred. In addition, reduced body weight is not considered a single
dose effect and would not be appropriate as a toxicity endpoint for
acute exposure scenarios.
v. There are no residual concerns with respect to the exposure
databases. The chronic and acute dietary food exposure assessment
utilizes reliable data on anticipated residues and percent crop treated
as well as default processing factors. The dietary drinking water
assessment utilized modeling results which included conservative
assumptions for the parent and all degradates of concern. Conservative
assumptions were used in the water models. Therefore, the water
exposure assessment will not underestimate the potential risks for
infants and children. Likewise, the use of maximum application rates
and central-to-high end inputs results in calculated residential
exposures that should not underestimate the risks to infants and
children from these requested uses.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic pesticide exposures are
safe by comparing aggregate exposure estimates to the acute population
adjusted dose (aPAD) and chronic population adjusted dose (cPAD). The
aPAD and cPAD represent the highest safe exposures, taking into account
all appropriate SFs. EPA calculates the aPAD and cPAD by dividing the
POD by all applicable UFs. For linear cancer risks, EPA calculates the
probability of additional cancer cases given the estimated aggregate
exposure. Short-, intermediate-, and chronic-term risks are evaluated
by comparing the estimated aggregate food, water, and residential
exposure to the POD to ensure that the MOE called for by the product of
all applicable UFs is not exceeded.
1. Acute risk. The acute aggregate risk assessment takes into
account exposure from dietary (food and water) consumption. Using the
exposure assumptions discussed in this unit for acute exposure, the
acute dietary exposure from food and water to avermectin B1
and its delta-8,9-isomer will occupy 27% of the aPAD for children 1 to
2 years old, the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
avermectin B1 and its delta-8,9-isomer from food and water
will utilize 47% of the cPAD for children 1 to 2 years old, the
population group receiving the greatest exposure. Based on the
explanation in Unit III.C.3., regarding residential use patterns,
chronic residential exposure to residues of avermectin B1
and its delta-8,9-isomer is not expected.
3. Short- and intermediate-term risk. Short- and intermediate-term
aggregate exposure takes into account short-term residential exposure
plus chronic exposure to food and water (considered to be a background
exposure level). High-end estimates of residential exposure were used,
while average values were used for food and drinking water exposure.
Avermectin B1 is currently registered for uses that could
result in short- and intermediate-term residential exposure and the
Agency has determined that it is appropriate to aggregate chronic
exposure through food and water with short- and intermediate-term
residential exposures to avermectin B1 and its delta-8,9-
isomer. Using the exposure assumptions described in this unit for
short-term exposures, EPA has concluded the combined short- and
intermediate-term food, water, and residential exposures result in
aggregate MOEs of 500 for children 1 to 2 years old, the population
group receiving the greatest exposure.
4. Aggregate cancer risk for U.S. population. Based on the absence
of a significant increase in tumor incidence in two rodent studies, EPA
classified avermectin B1 as ``not likely to be carcinogenic
to humans'' and it is, therefore, not expected to pose a cancer risk.
5. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population or to infants and children from aggregate
exposure to avermectin B1 and its delta-8,9-isomer residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methods for avermectin B1 in plant
and livestock commodities are available in PAM II. The methods have
been validated for citrus and processed fractions (Method I), ginned
cottonseed (Method IA), and bovine tissues and milk (Method II). These
methods determine residues in plant and livestock commodities at limits
of quantitation of 0.02 ppm for meat and meat byproducts and <=0.01 ppm
for other plant/livestock commodities. The limits of detection of the
methods for plant and livestock commodities is 0.001 ppm for each
analyte, equivalent to 0.002 ppm for two analyte peaks (i.e.,
avermectin B1a and its delta-8,9-isomer in one peak and
avermectin B1b and its delta-8,9-isomer in the other peak).
The plant methods used for data collection adequately measure the
residues of concern. The methods have been validated at 0.001, 0.002,
or 0.005 ppm (depending on the commodity and the method) for each of
two analyte peaks (avermectin B1a and its delta-8,9-isomer
in one peak and avermectin B1b and its delta-8,9-isomer in
the other peak), which means that the LOQs of the data collection
methods would be 0.002, 0.004 or 0.01 ppm.
The 1990 Pestrak database indicates that avermectin B1
and its metabolites are not recovered or not likely to be recovered by
FDA multiresidue methods. Therefore, the multiresidue methods can not
be used to determine residues for dietary exposure assessment and can
not be used as the primary enforcement method.
B. International Residue Limits
The Codex tolerance expressions for plants are consistent with the
U.S. tolerance expression.
C. Response to Comments
No comments were received to the Notices of Filing.
D. Revisions to Petitioned-For Tolerances
The correct commodity definitions are obtained from the ``Food and
Feed Commodity Vocabulary'', which can be found at https://www.epa.gov/
pesticides/foodfeed. Some proposed tolerance levels were raised based
on EPA's analysis of the residue data, EPA's assessment of the limits
of quantitation of the analytical methods, current livestock feed items
(OPPTS Guideline 860.100, Table 1 Feedstuffs, June 2008), and/or to
coordinate with Codex Maximum Residue Limits (MRLs).
V. Conclusion
Therefore, tolerances are established for combined residues of
avermectin B1 (a mixture of avermectins containing greater
than or equal to 80% avermectin B1a (5-O-demethyl avermectin
A1) and less than or equal to 20% avermectin B1b
(5-O-demethyl-25-de (1-
[[Page 39551]]
methylpropyl)-25-(1-methylethyl) avermectin A1)), and its
delta-8,9-isomer in/on cattle, fat at 0.03 ppm; cattle, meat byproducts
at 0.06 ppm; fruit, stone, group 12 at 0.09 ppm; goat, fat at 0.01 ppm;
hog, fat at 0.01 ppm; horse, fat at 0.01 ppm; nut, tree, group 14 at
0.01 ppm; pistachio at 0.01 ppm; sheep, fat at 0.01 ppm; and vegetable,
tuberous and corm subgroup 01C at 0.01 ppm.
Existing tolerances for cattle, fat and cattle, meat byproducts are
revised. Existing individual crop tolerances on almond, plum, potato,
and walnut are deleted and replaced by the establishment of new crop
group tolerances. Existing tolerances on almond, hulls and plum, prune,
dried are retained. The expression for existing mint tolerances is
corrected by deleting the term mint and replacing with peppermint, tops
at 0.010 ppm and spearmint, tops at 0.010 ppm.
VI. Statutory and Executive Order Reviews
This final rule establishes tolerances under section 408(d) of
FFDCA in response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled Regulatory Planning and
Review (58 FR 51735, October 4, 1993). Because this final rule has been
exempted from review under Executive Order 12866, this final rule is
not subject to Executive Order 13211, entitled Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
Protection of Children from Environmental Health Risks and Safety Risks
(62 FR 19885, April 23, 1997). This final rule does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA), 44 U.S.C. 3501 et seq., nor does it require any
special considerations under Executive Order 12898, entitled Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under section 408(d) of FFDCA, such as the tolerance in
this final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.) do not apply.
This final rule directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of section 408(n)(4) of FFDCA. As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled Federalism (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
Consultation and Coordination with Indian Tribal Governments (65 FR
67249, November 9, 2000) do not apply to this final rule. In addition,
this final rule does not impose any enforceable duty or contain any
unfunded mandate as described under Title II of the Unfunded Mandates
Reform Act of 1995 (UMRA) (Public Law 104-4).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act of 1995 (NTTAA), Public Law 104-113, section 12(d) (15 U.S.C. 272
note).
VII. Congressional Review Act
The Congressional Review Act, 5 U.S.C. 801 et seq., generally
provides that before a rule may take effect, the agency promulgating
the rule must submit a rule report to each House of the Congress and to
the Comptroller General of the United States. EPA will submit a report
containing this rule and other required information to the U.S. Senate,
the U.S. House of Representatives, and the Comptroller General of the
United States prior to publication of this final rule in the Federal
Register. This final rule is not a ``major rule'' as defined by 5
U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: July 28, 2009.
Lois Rossi,
Director, Registration Division, Office of Pesticide Programs.
0
Therefore, 40 CFR chapter I is amended as follows:
PART 180--AMENDED
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.449, the table to paragraph (a) is amended by revising
the entries for cattle, fat and cattle, meat byproducts; by removing
the entries for almond, plum, mint, potato and walnut; and by adding
alphabetically, the remaining entries in the table to read as follows:
180.449 Avermectin B1 and its delta-8,9-isomer; tolerances
for residues.
(a) * * *
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
* * * * *
Cattle, fat.................................................. 0.03
Cattle, meat byproducts...................................... 0.06
* * * * *
Fruit, stone, group 12....................................... 0.09
Goat, fat.................................................... 0.01
* * * * *
Hog, fat..................................................... 0.01
* * * * *
Horse, fat................................................... 0.01
* * * * *
Nut, tree, group 14.......................................... 0.01
* * * * *
Peppermint, tops............................................. 0.010
Pistachio.................................................... 0.01
* * * * *
Sheep, fat................................................... 0.01
* * * * *
Spearmint, tops.............................................. 0.010
Vegetable, tuberous and corm, subgroup 01C................... 0.01
------------------------------------------------------------------------
* * * * *
FR Doc. E9-19006 Filed 8-6-09; 8:45 am
BILLING CODE 6560-50-S